Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats-Reference-Cited by-同舟云学术

Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats

Published:2018-02-18 Issue:5 Volume:235 Page:1439-1453
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Maggio Sarah E.,Saunders Meredith A.,Baxter Thomas A.,Nixon Kimberly,Prendergast Mark A.,Zheng Guangrong,Crooks Peter,Dwoskin Linda P.,Slack Rachel D.,Newman Amy H.,Bell Richard L.,Bardo Michael T.

Funder

National Institutes of Health

National Institute on Alcohol Abuse and Alcoholism

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s00213-018-4853-4/fulltext.html

Reference82 articles.

1. Alcohol Facts and Statistics. In: Alcoholism NIoAAa (ed). U.S. Department of Health and Human Services, June 2017, www.niaaa.nih.gov

2. Avelar AJ, Cao J, Newman AH, Beckstead MJ (2017) Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons. Neuropharmacology 123:410–419